Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models
2022 · Clinical & Translational Immunology · 100 citations
https://doi.org/10.1002/cti2.1373
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
327
Citations
7
h-index
6
i10-index
Kevin Bray is an academic researcher from Regeneron (United States). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research & T-cell and B-cell Immunology. The author has an h-index of 7, co-authored 11 publications.
https://doi.org/10.1002/cti2.1373
https://doi.org/10.1126/scitranslmed.ado9371
Click to start Chat